REPLIGEN CORP Total Assets

Quick Answer

REPLIGEN CORP reported Total Assets of $2.95 billion for fiscal year 2025.

REPLIGEN CORP Total Assets — Annual History

Fiscal Year Total Assets YoY Change
2025 $2.95B +4.2%
2024 $2.83B -0.1%
2023 $2.83B +12.1%
2022 $2.52B +7.1%
2021 $2.36B +23.9%
2020 $1.90B +35.9%
2019 $1.40B +80.7%
2018 $774.62M +4.2%
2017 $743.52M +157.4%
2016 $288.91M +97.6%
2015 $146.24M +14.0%
2014 $128.29M +8.1%
2013 $118.64M +22.3%
2012 $97.01M +27.5%
2011 $76.06M +5.2%
2011 $72.29M

Quarterly Total Assets

Quarter Ending Total Assets YoY QoQ
September 30, 2025 $2.92B +3.3% +0.8%
June 30, 2025 $2.90B +1.4% +1.7%
March 31, 2025 $2.85B +0.1% +0.8%
December 31, 2024 $2.83B -0.1% -0.0%
September 30, 2024 $2.83B +12.6% -1.1%
June 30, 2024 $2.86B +12.3% +0.4%
March 31, 2024 $2.85B +12.3% +0.6%
December 31, 2023 $2.83B +12.1% +12.6%
  • REPLIGEN CORP showed an increase of +4.2% in Total Assets compared to the prior fiscal year.
  • Over the 2011–2025 period, REPLIGEN CORP’s total assets has grown by 3980.1% (from $72.29 million to $2.95 billion).
  • The most recent figure is from REPLIGEN CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment